# Study to Evaluate MEDI-534 in Healthy Adults

> **NCT00111878** · — · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 120 (—)

## Conditions studied

- Respiratory Syncytial Virus Infections
- Parainfluenza Infections

## Interventions

- **DRUG:** MEDI-534

## Key facts

- **NCT ID:** NCT00111878
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2005-12
- **Target enrollment:** 120 (—)
- **Last updated:** 2007-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111878, "Study to Evaluate MEDI-534 in Healthy Adults". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00111878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*